ACHD | adult patients with congenital heart disease |
CHD | congenital heart disease |
VKA | Vitamin K antagonist |
NOACs | Non-vitamin K oral anticoagulants |
NOS | Newcastle-Ottawa scale |
QoL | Quality of Life |
ACHD | adult patients with congenital heart disease |
CHD | congenital heart disease |
VKA | Vitamin K antagonist |
NOACs | Non-vitamin K oral anticoagulants |
NOS | Newcastle-Ottawa scale |
QoL | Quality of Life |